1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Summary of complication and cure rates in recent larger series with embolization predominantly or exclusively using Onyx

SeriesNo. of PatientsPermanent Morbidity and Mortality (%)Cure by Embolization Alone (%)
Mounayer et al39411 (11.7)26 (28)*
Weber et al5939 (9.7)19 (20.4)
Katsaridis et al710111 (10.9)28 (27.7)*
Pierot et al2486 (12.5)2 (4.1)*
van Rooij et al6443 (6.8)7 (15.9)
Perez-Higueras et al8458 (17.7)10 (22.2)
Panagiotopoulos et al1829 (11.3)16 (19.5)
  • * Further endovascular treatment was planned in some patients.